Trial NCT02576275

View at ClinicalTrials.gov 
Org. Study IDs: IPI-145-22

Last trial update was posted on 2021-03-17

MeSH Interventions

Bendamustine Hydrochloride Rituximab

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin

Other Conditions

Follicular Lymphoma Indolent Non-Hodgkin's Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma

Stopping Reasons

The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID